New FDA Regulations on E-Cigarettes Targeting Minors in Effect

New FDA Regulations on E-Cigarettes Targeting Minors in Effect

In an effort targeted at minors, new FDA regulations on e-cigarettes go into effect today, including banning the sale of the products to people under the age of 18 and asking for ID for anyone that looks under the age of 27.

In essence, the new regulations bring e-cigarettes, as well as the new trend of vaping, under the same rules that govern the sale of traditional tobacco products, such as regular cigarettes. The regulations are a result of statistics in recent years that show while the number of teens smoking regular cigarettes has declined, the percentage of teens using e-cigarettes has skyrocketed.

E-cigarettes work by heating up a flavored liquid that contains nicotine into a vapor that is then inhaled. But health officials worry some companies have been targeting minors with flavors such as candy cane and marshmallow.

The new regulations, which also cover hookahs and cigars, ban e-cigarette vending machines, except in adults-only establishments, free samples, and require printed warnings on the packaging about the dangers of using the product.

The FDA is also being given authority to approve tobacco products not previously regulated that came on the market after February 15, 2007. This means that e-cigarette makers will have two years to submit their products for a safety review by the agency. They will have about a year to continue selling their products as the review takes place.

New requirements also mandate that manufacturers will have to register their products with the FDA, and provide a list of ingredients in them, including “harmful and potentially harmful” substances.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement